UF’s COVID Restore Clinic Treats Long Haulers
Dr. Irene Estores, medical director of the Integrative Medicine Program at UF leads the COVID Restore Clinic to treat long haulers. According to the WHO definition, long COVID “occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.”
UF Health Scientists Develop Novel Method of Cryopreserving Lung Tissue for COVID-19 Research
A team of University of Florida Health researchers have developed a method to cryopreserve lung tissue at minus-184 degrees Fahrenheit that give scientists an important new tool to study how the coronavirus infects individuals.
UF Health Psychiatrist Talks About the Mental Health Challenges Posed by COVID-19
Jacqueline Hobbs, M.D., Ph.D., an associate professor in the University of Florida College of Medicine’s department of psychiatry, discusses the burden of coping with the stress caused by the upheaval of normal life and the need to pay closer attention to our mental well-being.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of Its SARS-CoV-2 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice With Intramuscular and Intranasal Adjuvants
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator and licensed by the company from the National Institutes of Health (NIH) generates neutralizing antibodies in mice after immunization against SARS-CoV-2, when administered with several novel intramuscular (IM) and intranasal (IN) adjuvants.
CFO of Life Science Startup Axogen Shares How Firm Navigated Pandemic’s Health Care Disruptions
UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic.
Breast Milk of Mothers Who Received COVID-19 Vaccine Contains Antibodies That Fight Illness
The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.
DiaCarta Receives CE/IVD for its New COVID 19 test that Identifies Delta Plus and New Variants
UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy, announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and rest of the world.
UF Team Identifies Novel Targets for COVID-19 Antivirals
A multidisciplinary team of researchers at the University of Florida is making progress in their search for targets that could be used for developing treatments for infections with COVID-19. The team posted a paper to bioRxiv reporting the identification of 53 novel genes and pathways that could become druggable targets for antiviral therapies for COVID-19 plus a broad array of coronavirus types.
